InspireMD to Announce Six-Month Results from the MGuard™ Embolic Protection Stent (EPS) MASTER Trial at EuroPCR

InspireMD to Announce Six-Month Results from the MGuard™ Embolic Protection Stent (EPS) MASTER Trial at EuroPCR (via PR Newswire)

BOSTON and TEL AVIV, Israel, May 16, 2013 /PRNewswire/ —  -Strong Conference Presence to Include Presentations/EducationalEvents Featuring the MGuard™ Embolic Protection Stent-  – Company to Host Conference Call on Thursday, May 23rd to Review MASTER Data – InspireMD, Inc. (“InspireMD” or the…